Managed Care Calendar

Poll

Monthly Tabloid Publication

 
 

Editorial Description

First Report - Managed Care® has provided formulary and reimbursement decision makers cutting edge clinical, economic, and legislative developments of direct interest to and affecting the managed markets since 2004.

This mailed monthly tabloid publication will continue to provide original news articles, late-breaking development reports, comprehensive coverage of major medical (eg, AHA, ACC) and managed care (eg, AMCP) conferences from around the nation, new product announcements as well as legislative developments affecting the managed markets (eg, MMA).

Advertising Inquires

VP and Group Publisher

Publisher

Christopher Ciraulo

Michael DiBella

610.560.0500 x311

610.560.0500 x314

cciraulo@hmpcommunications.com

mdibella@hmpcommunications.com

 


REQUIP XL is an oral dopamine agonist medication for Parkinson’s disease and had demonstrated significant improvement in the symptoms of Parkinson’s disease.

 

 


The Role of Immune Function in the Changing Landscape of RRMS Therapies

 

 

 


Gastroesophageal reflux disease (GERD) is an important
managed care health concern because it is one of the most common gastrointestinal (GI) disorders in the United
States. GERD affects nearly 18.6 million Americans, according to a national healthcare database analysis.

 

 


Parkinson’s disease (PD) is a progressive
and disabling neurologic disorder. The disease is the most prevalent type of parkinsonism, a clinical syndrome caused by lesions in the basal ganglia, predominantly in the substantia nigra, which produces deficits in motor behavior.

Get Access to the Print and Online Edtions

Managed Care First Report

CLICK HERE TO CONTINUE »

Web Statistics